XML 21 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Market Offering
Common Stock
Common Stock
Market Offering
Additional Paid-in Capital
Additional Paid-in Capital
Market Offering
Accumulated Deficit
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2021     27,607,954        
Stockholders' equity, beginning balance at Dec. 31, 2021 $ 152,787   $ 2   $ 405,680   $ (252,895)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from initial public offering, net of issuance costs (in shares)       3,827,567      
Issuance of common stock from at the market offering, net of issuance costs   $ 15,736   $ 1   $ 15,735  
Stock-based compensation expense 7,400       7,400    
Stock option exercises (in shares)     79,553        
Stock option exercises 224       224    
Net loss (53,810)           (53,810)
Stockholders' equity, ending balance (in shares) at Dec. 31, 2022     31,515,074        
Stockholders' equity, ending balance at Dec. 31, 2022 122,337   $ 3   429,039   (306,705)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from initial public offering, net of issuance costs (in shares)     157,037 7,431,981      
Issuance of common stock from at the market offering, net of issuance costs 93 $ 18,297   $ 1 93 $ 18,296  
Stock-based compensation expense 8,008       8,008    
Stock option exercises (in shares)     2,956        
Stock option exercises 7       7    
Net loss (37,368)           (37,368)
Stockholders' equity, ending balance (in shares) at Dec. 31, 2023     39,107,048        
Stockholders' equity, ending balance at Dec. 31, 2023 $ 111,374   $ 4   $ 455,443   $ (344,073)